Sonic Incytes Medical Corp. is the developer of Velacur^{TM –} the first handheld 3D liver health assessment solution. Cleared by the FDA, Velacur^TM is a breakthrough, non-invasive imaging test that quantifies liver elasticity and attenuation with reliability and accuracy comparable to MRI. Velacur^TM offers providers a fast, accurate and practical way to measure a patient’s liver health and grow their practice. In addition, it is a cost-effective tool for pharma to screen patients for NASH clinical trials and monitor therapeutic effectiveness of promising NASH drugs.

Request a private demo at www.velacur.com or learn more at www.sonicincytes.com